Loading
Cagrilintide · research summary
Journal of diabetes science and technology · 2026. Summary drawn from the study's full text. Each statement is followed by the exact sentence it comes from. This is a research summary, not medical advice.
Usability evaluation of a dual-chamber pen autoinjector
“This study evaluated the usability of the CagriSema dual-chamber pen, a single-dose, single-use, pre-filled autoinjector for once-weekly subcutaneous administration of a fixed-dose combination of cagrilintide and semaglutide.”
Adults with overweight/obesity or type 2 diabetes
“Adults with overweight/obesity (n = 85) or type 2 diabetes (n = 65) performed simulated injections after standardized training.”
150 participants
“Adults with overweight/obesity (n = 85) or type 2 diabetes (n = 65) performed simulated injections after standardized training.”
All but one participant completed the injection successfully
“All but one participant completed the injection successfully.”
Median training time was 3 minutes and time to prepare and inject was 15 seconds
“Median training time was 3 minutes, and time to prepare and inject was 15 seconds.”
Participants rated the device easy/very easy to use, learn, and convenient
“Participants rated the device easy/very easy to use (100%), easy/very easy to learn (98.7%), and an injection with the pen convenient (99.3%).”
Source: PubMed 42366647 · DOI 10.1177/19322968261461530 · all study summaries